Press Releases
August 21, 2011

Venatorx Pharmaceuticals has been awarded a Phase 1 SBIR Grant for novel approaches to address multi-drug resistant gram-negative infections. The company may receive up to $600,000 of funding under...

Archive: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2011 | 2010